ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag national cancer institute developmental biology ecology culture

Microfluidics: Biology’s Liquid Revolution
Laura Tran, PhD | Feb 26, 2024 | 8 min read
Microfluidic systems redefined biology by providing platforms that handle small fluid volumes, catalyzing advancements in cellular and molecular studies.
One Protein to Rule Them All
Shelby Bradford, PhD | Feb 28, 2024 | 10+ min read
p53 is possibly the most important protein for maintaining cellular function. Losing it is synonymous with cancer.
Maximize In Vitro Culture Possibilities
Linda Raab | Oct 25, 1998 | 4 min read
From Redmond, et al., "Perfused transcapillary smooth muscle and endothelial cell co-culture--a novel in vitro model," In Vitro Cellular & Developmental Biology--Animal, Volume 31:601-609. Copyright 1995 by the Society for In Vitro Biology. Reproduced with permission of the copyright owner. The Cellmax™ culture system uses hollow fiber bioreactor technology in applications as diverse as secreted protein production, lymphocyte expansion, and cellular co-cultivation. The concept of
Cancer Institute Turns To Cell Line Screening
David Ansley | Apr 29, 1990 | 6 min read
Looking for compounds to kill tumors, Michael Boyd abandons leukemic mice and tries a radically new, unprecedentedly large assay In a sharp break from its past, the National Cancer Institute has abandoned a 30-year-old system for finding compounds that kill tumors and has replaced it with an elaborate but unproven factory-style operation. In the new program, unique in its scope, 20,000 compounds and extracts will be tested against a broad array of human tumor cells each year. The compounds wi
Guts and Glory
Anna Azvolinsky | Apr 1, 2016 | 9 min read
An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.
The Ecology of Tumors
Paraic A. Kenny, Celeste M. Nelson, and Mina J. Bissell | Apr 1, 2006 | 10+ min read
FEATUREThe Ecology of Tumors   Courtesy of Nasa Ames Research CenterBy perturbing the microenvironment, wounds and infection may be key to tumor development.BY PARAIC A. KENNY, CELESTE M. NELSON, AND MINA J. BISSELLNo tumor is an island. Chemical and physical forces exerted by the diverse cellular populations that surround a tumor - its so-called microenvironment - shape development and progression. Manipulating these 'ecologi
On the left is a normally developing mouse embryo, on the right is a slightly larger mouse embryo that also contains horse cells that glow green.
Chimera research opens new doors to understanding and treating disease
Hannah Thomasy, PhD, Drug Discovery News | Aug 9, 2023 | 10 min read
Animals with human cells could provide donor organs or help us understand neuropsychiatric disorders.
Contributors
Catherine Offord | Apr 1, 2016 | 3 min read
Meet some of the people featured in the April 2016 issue of The Scientist.
Dedifferentiation: More Than Reversing Fate
Ricki Lewis | Aug 29, 2004 | 5 min read
Courtesy of Cecil Fox and the National Cancer InstituteDifferentiation, the stepwise specialization of cells, and transdifferentiation, the apparent switching of one cell type into another, capture much of the stem cell spotlight. But dedifferentiation, the developmental reversal of a cell before it reinvents itself, is an important process, too. This loss of specialization is believed to factor heavily into stem-cell culture techniques and pathological conditions such as cancer. Determining its
Cancer Research Institute Recognizes Immunologists With Annual Coley Awards
Neeraja Sankaran | Aug 20, 1995 | 3 min read
Immunology Author: Neeraja Sankaran This year, the New York City-based Cancer Research Institute (CRI) honored three prominent scientists with its William B. Coley Awards for Distinguished Research, which recognize outstanding research in the field of cancer immunology. The awards were presented at a black-tie dinner on June 28. Malcolm A.S. Moore, a hematologist at Memorial Sloan-Kettering Cancer Center (MSKCC), New York, and Timothy A. Springer, a professor of pathology at the Center for Blo

Run a Search

ADVERTISEMENT